top of page

Chronicled and Deloitte ally to accelerate blockchain in the life sciences and health care industry,


Chronicled and Deloitte today announced an alliance to bring blockchain-powered solutions to the life sciences and health care industry. The alliance will leverage technology and solutions powered by Chronicled's MediLedger Network, a blockchain-enabled network for the life sciences industry, to bring interoperability, security and efficiency to processes between companies in revenue management and the pharmaceutical supply chain.


Part of the new alliance between Chronicled and Deloitte includes a solution to help fight counterfeits and fraud in the medication used for the treatment of COVID-19, an issue that has increased dramatically since the start of the pandemic. MediLedger's product verification solution can enable pharmacies and hospitals to authenticate high risk or suspect products. It works through a barcode scan that validates product data against the original manufacturer's data. MediLedger already enables verification by pharmaceutical wholesalers for more than 95% of drugs being re-sold in the US and is among the first blockchain-based solutions deployed in commercial use around the world.


"Chronicled has the potential to radically reshape the way product is tracked and managed within the health care ecosystem," said David Carlson, managing director, Deloitte Consulting LLP, and leader for the Chronicled relationship. "As the life sciences industry moves quickly to get innovative therapies to market during this critical time, stakeholders are looking for solutions that enhance pricing transparency while creating an efficient mechanism to exchange product use and financial information. Chronicled is an important player in the effort to better collaborate across the value chain and Deloitte is well positioned to drive large scale industry transformation."


In addition to product verification on MediLedger, Chronicled will launch a second solution this summer called Contracts & Chargebacks aimed at eliminating disputes, improving cash flow and identifying revenue leakage in the chargeback process between manufacturers, distributors and group purchasing organizations. MediLedger can enable significant improvements to these processes, helping companies transact and share data with each other and avoid delays, inaccuracies, poor customer service and lost revenue.


"Chronicled is pleased to be working with Deloitte to offer the MediLedger Network to the health care industry, most importantly to do our part in the fight against COVID-19," said Susanne Somerville, CEO of Chronicled. "Combining Chronicled's innovative product verification and contracts and chargebacks solutions and Deloitte's deep experience with implementation and the complexities of these business processes, we have the ability to create tremendous value for the industry and the world."

SOURCE Chronicled

Comentarios


connexion_panel_edited.jpg
CXO_8-in-1.png
subscribe_button.png

 

Disclaimer:

The information contained in this site is for reference only. While we have made every attempt to ensure that the information contained in this site has been obtained from reliable sources, we are not responsible for any errors or omissions, or for the results obtained from the use of this information. All information in this site is provided "as is", with no guarantee of completeness, accuracy, timeliness or of the results obtained from the use of this information, and without warranty of any kind, express or implied, including, but not limited to warranties of performance, merchantability and fitness for a particular purpose. In no event will Ho Hon Asia Limited, its related partnerships or corporations, or the partners, agents or employees thereof be liable to you or anyone else for any decision made or action taken in reliance on the information in this site or for any consequential, special or similar damages, even if advised of the possibility of such damages.
Certain links in this site connect to other websites maintained by third parties over whom we have no control. We make no representations as to the accuracy or any other aspect of information contained in other websites.

2025 @ Inno-Thought and its affiliates. All rights reserved.

bottom of page